Results 211 to 220 of about 114,353 (299)

Mpox (Monkeypox) in Pregnancy Updates

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Mpox is a zoonotic viral disease caused by the monkeypox virus, with potential for significant morbidity across all population groups, including pregnant individuals and neonates. Pregnancy represents an immunologically vulnerable state, rendering affected mothers more susceptible to severe disease progression.
Yeshey Dorjey, Deep Kiran Chhetri
wiley   +1 more source

RDC/TMD axis II criteria in defining temporomandibular disorders. a cross-sectional study. [PDF]

open access: yesBMC Oral Health
Ardıç M   +4 more
europepmc   +1 more source

LED Photobiomodulation for Pain Reduction in Temporomandibular Disorder: A Randomized, Controlled, and Blinded Clinical Trial

open access: yesJournal of Biophotonics, Volume 19, Issue 3, March 2026.
This randomized, controlled, and blinded trial demonstrated that photobiomodulation (PBM) with 850 nm (infrared) and 660 nm (red) LED clusters effectively reduced pain in patients with temporomandibular dysfunction (TMD). ABSTRACT This clinical, randomized, controlled, and blinded trial evaluated photobiomodulation (PBM) using 850 nm (infrared) and 660 
Lucía Píriz Trindade   +11 more
wiley   +1 more source

From Pharmaceutical to Biophysical Therapies: New Horizons in Inflammatory Bowel Disease Management

open access: yesJCC Plus, Volume 1, Issue 2, March 2026.
Important limitations exist in the current pharmacological landscape of Inflammatory Bowel Disease (IBD), such as variable response rates and treatment‐limiting adverse effects. In this review, we perform a critical assessment of the current literature on novel multimodal biophysical approaches showing alternative mechanisms of action to, and potential
Benedetta Ricchi   +7 more
wiley   +1 more source

Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT Chenodeoxycholic acid (CDCA) is an essential drug for patients with rare metabolic disease cerebrotendinous xanthomatosis (CTX). To ensure continuation of treatment, the Amsterdam UMC hospital pharmacy developed pharmacy compounded CDCA capsules when the authorized CDCA capsules were no longer available for Dutch patients.
Natalja Bouwhuis   +9 more
wiley   +1 more source

Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 124-131, March 2026.
ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy